HR 5298
115th Congress
House
Crime and Law Enforcement
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Modernizing Drug Enforcement Act of 2018
Introduced: March 15, 2018
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 30, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Mar 16, 2018
Referred to the Subcommittee on Health.
Mar 15, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 15, 2018
Introduced in House
Plain-English summary
Modernizing Drug Enforcement Act of 2018
This bill deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Committees of jurisdiction
4
Cosponsors
1